InterCure Ltd
TASE:INCR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
I
|
InterCure Ltd
TASE:INCR
|
IL |
|
Egetis Therapeutics AB (publ)
STO:EGTX
|
SE |
|
K
|
KGHM Polska Miedz SA
OTC:KGHPF
|
PL |
|
Willamette Valley Vineyards Inc
NASDAQ:WVVI
|
US |
|
Derluks Yatirim Holding AS
IST:DERHL.E
|
TR |
|
T
|
Talant Optronics suzhou Co Ltd
SZSE:301045
|
CN |
|
A
|
Asiamet Resources Ltd
OTC:KMGLF
|
CA |
|
City Union Bank Ltd
BSE:532210
|
IN |
|
J
|
JBDI Holdings Ltd
NASDAQ:JBDI
|
SG |
|
Kyung Dong Navien Co Ltd
KRX:009450
|
KR |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is INCR's stock price target?
Not Available
INCR doesn't have any price targets made by Wall Street professionals.
What is InterCure Ltd's Revenue forecast?
Projected CAGR
17%
For the last 14 years the compound annual growth rate for InterCure Ltd's revenue is 24%. The projected CAGR for the next 3 years is 17%.
What is InterCure Ltd's Operating Income forecast?
Projected CAGR
43%
The compound annual growth rate of InterCure Ltd's operating income for the next 3 years is 43%.